Scilex Holding Co. (SCLX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
4.74 +0.13 (+2.82%) 04/30/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 4.74 unch (unch) 16:03 ET
for Wed, Apr 30th, 2025
Results
download Want to compare other data? Select Fields| Symbol | SCLX | ALGS | KZR | ||
| Company | Scilex Holding Co. | Aligos Therapeutics Inc | Kezar Life Sciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.98 | 5.10 | 4.45 | ||
| High | 5.59 | 5.58 | 4.45 | ||
| Low | 4.51 | 4.77 | 4.38 | ||
| Last | 4.74 | 5.58 | 4.38 | ||
| Change | +0.13 | +0.33 | -0.01 | ||
| % Change | +2.82% | +6.29% | -0.23% | ||
| Volume | 504,500 | 67,500 | 4,200 | ||
| 20-Day Average Volume | 158,684 | 180,845 | 20,650 | ||
| Previous Close | 4.61 | 5.25 | 4.39 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 6.62 | 5.20 | 4.30 | ||
| 20-Day Raw Stochastic | 14.28% | 43.86% | 63.86% | ||
| 20-Day Relative Strength | 33.43% | 35.41% | 42.20% | ||
| Weighted Alpha | -91.25 | -73.22 | -59.54 | ||
| Today's Opinion | 100% Sell | 72% Sell | 88% Sell | ||
| Previous Opinion | 100% Sell | 88% Sell | 88% Sell | ||
| Last Month's Opinion | 100% Sell | 72% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +16.75% since 04/23/25 | +4.10% since 04/23/25 | -4.37% since 04/23/25 | ||
| Low | 4.00 on 04/24/25 | 4.77 on 04/30/25 | 4.33 on 04/28/25 | ||
| High | 5.74 on 04/29/25 | 6.00 on 04/25/25 | 4.81 on 04/24/25 | ||
| 1-Month | |||||
| %Chg | -44.34% since 03/28/25 | -38.82% since 03/28/25 | -10.98% since 03/28/25 | ||
| Low | 3.60 on 04/22/25 | 3.76 on 04/11/25 | 3.62 on 04/04/25 | ||
| High | 11.59 on 04/02/25 | 8.79 on 03/31/25 | 4.97 on 03/31/25 | ||
| 3-Month | |||||
| %Chg | -69.22% since 01/30/25 | -76.50% since 01/30/25 | -32.41% since 01/30/25 | ||
| Low | 3.60 on 04/22/25 | 3.76 on 04/11/25 | 3.62 on 04/04/25 | ||
| High | 15.12 on 01/31/25 | 29.54 on 02/10/25 | 6.65 on 01/31/25 | ||
| 6-Month | |||||
| %Chg | -85.62% since 10/30/24 | -42.89% since 10/30/24 | -46.52% since 10/30/24 | ||
| Low | 3.60 on 04/22/25 | 3.76 on 04/11/25 | 3.62 on 04/04/25 | ||
| High | 39.90 on 11/06/24 | 46.80 on 01/06/25 | 8.17 on 10/31/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 32,080 | 32,100 | 32,072 | ||
| Shares Outstanding, K | 6,959 | 6,114 | 7,306 | ||
| Annual Sales | 56,590,000 | 3,950,000 | 0 | ||
| Annual Net Income | -72,810,000 | -131,210,000 | -83,740,000 | ||
| Last Quarter Sales | 14,900,000 | 630,000 | 0 | ||
| Last Quarter Net Income | -6,460,000 | -82,150,000 | -20,220,000 | ||
| 60-Month Beta | 1.04 | 2.72 | 0.61 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -6.29 on 01/17/25 | -3.41 on 03/10/25 | -2.77 on 03/25/25 | ||
| Latest Earnings Date | 05/12/25 | 05/06/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||